Articles from JTC Team, LLC
JTC Team to Host Virtual Investor Spotlight Event Featuring SurgePays, Inc.
- Live moderated video webcast with Brian Cox, President and CEO of SurgePays on Wednesday, July 27th at 11:00 AM ET -
By JTC Team, LLC · Via AccessWire · July 22, 2022
JTC Team to Host Virtual Investor Innovations in Oncology Event Featuring AIM ImmunoTech
- Live video webcast with moderated fireside chat with members of the AIM leadership team and Key Opinion Leader, Professor Casper van Eijck, Ph.D. of Erasmus Medical Center, on Monday, July 25th at 8:30 AM ET -
By JTC Team, LLC · Via AccessWire · July 19, 2022
JTC Team to Host Virtual Investor Innovation in Oncology Featuring Xenetic Biosciences
- Live video webcast with moderated roundtable with members of the Xenetic leadership team and surgical oncology Key Opinion Leader, Allan Tsung, MD on Thursday, June 9th at 11:00 AM ET -
By JTC Team, LLC · Via AccessWire · June 2, 2022
JTC Team to Host Virtual Investor Innovations in MedTech Event Featuring Melzi Surgical
- Live video webcast with moderated fireside chat with members of the Melzi leadership team and surgical Key Opinion Leaders on Wednesday, June 8th at 11:00 AM ET -
By JTC Team, LLC · Via AccessWire · June 1, 2022
JTC Team to Host Virtual Investor Niemann-Pick Disease Type C Spotlight Event Featuring Cyclo Therapeutics
- Live video webcast with moderated fireside chat with members of the Cyclo Therapeutics leadership team and Global Principal Investigator for the Phase 3 study, Professor Caroline Hastings, MD, on Monday, May 16th at 2:00 PM ET - FRENCHTOWN, NJ / ACCESSWIRE / May 12, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Niemann-Pick Disease Type C
By JTC Team, LLC · Via AccessWire · May 12, 2022
JTC Team to Host Virtual Investor CEO Spotlight Event Featuring Outlook Therapeutics
Live Video Webcast Event with Russ Trenary, President and CEO of Outlook Therapeutics on Wednesday, May 11th at 1:00 PM ET FRENCHTOWN, NJ / ACCESSWIRE / May 9, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor CEO Spotlight Event Featuring Outlook Therapeutics on Wednesday, May 11, 2022 at 1:00 PM ET. Access the event here. Outlook Therapeutics is
By JTC Team, LLC · Via AccessWire · May 9, 2022
JTC Team to Host Virtual Investor Management and KOL Roundtable Event - Featuring Palisade Bio
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
By JTC Team, LLC · Via AccessWire · May 3, 2022
JTC Team to Host Virtual Investor Innovation in Dermatology Spotlight Event Featuring Novan, Inc.
- Live video webcast event with members of Novan, Inc. management on Tuesday, April 26th at 2:00 PM ET - FRENCHTOWN, NJ / ACCESSWIRE / April 25, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Innovation in Dermatology Spotlight Featuring Novan, Inc. on Tuesday, April 26, 2022 at 2:00 PM ET. Access the event here. Novan, Inc. is a specialty
By JTC Team, LLC · Via AccessWire · April 25, 2022
JTC Team Announces Continuation of its Virtual Investor Spotlight Series with NASDAQ: AEZS, NASDAQ: CNSP, and NASDAQ: AREC
- Live video webcast events on Thursday, April 14 at 10 AM ET, 11:30 AM ET and 1 PM ET - FRENCHTOWN, NJ / ACCESSWIRE / April 13, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced the continuation of its Virtual Investor Spotlight Series to be held on Thursday, April 14, 2022. Access the full series of events here. Thursday, April 14, 2022 - 10:00 AM ET: CEO Spotlight Featuring
By JTC Team, LLC · Via AccessWire · April 13, 2022
JTC Team to Host Virtual Investor Alzheimer's Disease Spotlight Featuring Cyclo Therapeutics on Tuesday, April 5th at 1:00 PM ET
Featuring preeminent neuroscientist and world-renowned researcher, Dr. Cynthia Lemere, who serves in the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital and as Associate Professor of Neurology at Harvard Medical School in Boston Joined by members from the Cyclo Therapeutics management team N. Scott Fine, Chief Executive Officer, and Lise Lund Kjems, MD, PhD, Chief Medical Officer FRENCHTOWN, NJ / ACCESSWIRE / March 29,
By JTC Team, LLC · Via AccessWire · March 29, 2022
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2022 Top Picks Conference January 25-27, 2022. As part of the virtual
By JTC Team, LLC · Via AccessWire · January 12, 2022
JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating companies - PITTSTOWN, NJ / ACCESSWIRE / November 4, 2021 / November 4, 2021 - JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Roundtable Event November 16-18,
By JTC Team, LLC · Via AccessWire · November 4, 2021
JTC Team to Host Virtual Investor 'Ask the CEO' Event on April 21st, 22nd, and 23rd
- Specialized event intended to provide retail investors direct access to ask their questions to participating members of management - Participating companies include American Resources Corporation (NASDAQAREC), urban-gro, Inc. NASDAQ:UGRONASDAQUGRO)
By JTC Team, LLC · Via AccessWire · April 15, 2021